Literature DB >> 30954455

Dipeptidyl nitrile derivatives have cytostatic effects against Leishmania spp. promastigotes.

José C Quilles1, Daiane Y Tezuka2, Carla D Lopes3, Fernanda L Ribeiro4, Charles A Laughton5, Sérgio de Albuquerque6, Carlos A Montanari7, Andrei Leitão8.   

Abstract

Cysteine proteases are involved in critical cell processes to the protozoa from Leishmania genus, and their inhibition is a therapeutic alternative to treat the disease. In this work, derivatives of dipeptidyl nitriles acting as reversible covalent inhibitors of cysteine proteases were studied as cytostatic agents. The proteolytic activity inside the living and lysed parasite cells was quantified using a selective substrate for cysteine proteases (Z-FR-MCA) from Leishmania amazonensis and L. infantum. The overall proteolytic activity of intact cells and even cell extracts was only marginally affected at high concentrations, with the observation of cytostatic activity and cell cycle arrest of promastigotes. However, the cytotoxic effects were only observed for infected J774 macrophages, which impaired further analysis of the amastigote infection. Therefore, the proteolytic inhibition in intact L. amazonensis and L. infantum promastigotes had no relationship to the cytostatic activity, which emphasizes that these dipeptidyl nitriles act through another mechanism of action.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Cell-based assays; Cytostatic activity; Dipeptidyl nitriles; Leishmaniasis

Mesh:

Substances:

Year:  2019        PMID: 30954455     DOI: 10.1016/j.exppara.2019.04.001

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  1 in total

1.  Apoferritin encapsulation of cysteine protease inhibitors for cathepsin L inhibition in cancer cells.

Authors:  José C Quilles Junior; Fernanda Dos Reis Rocho Carlos; A Montanari; Andrei Leitão; Viviane W Mignone; Maria Augusta Arruda; Lyudmila Turyanska; Tracey D Bradshaw
Journal:  RSC Adv       Date:  2019-11-11       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.